HOOKIPA PHARMA INC (HOOK) Stock Price, Quote, News and Overview
NASDAQ:HOOK - Nasdaq - US43906K2096 - Common Stock - Currency: USD
HOOK Quote, Performance and Key Statistics
HOOKIPA PHARMA INC
NASDAQ:HOOK (2/5/2025, 10:25:28 AM)
1.94
+0.06 (+3.19%)
The current stock price of HOOK is 1.94 USD. In the past month the price increased by 1.08%. In the past year, price decreased by -72.21%.
HOOK Latest News, Press Releases and Analysis
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative...
Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE...
HOOKIPA Pharma Inc - FORM 8 (OPD)
NEW YORK and VIENNA, Austria, Jan. 08, 2025 (GLOBE NEWSWIRE) -- FORM 8 (OPD) PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFERRules 8.1 and...
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements
NEW YORK and VIENNA, Austria, Jan. 07, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a clinical-stage...
HOOK Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.08 | 341.30B | ||
| AMGN | AMGEN INC | 15.38 | 163.89B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 958.15 | 125.84B | ||
| GILD | GILEAD SCIENCES INC | 22.5 | 124.20B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.54 | 77.93B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.78B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.62B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.55B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.30B | ||
| NTRA | NATERA INC | N/A | 23.39B | ||
| BIIB | BIOGEN INC | 8.97 | 21.34B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 15.69B |
Related stock screener links
About HOOK
Company Profile
HOOKIPA Pharma Inc is a US-based company operating in Biotechnology industry. The company is headquartered in New York City, New York and currently employs 151 full-time employees. The company went IPO on 2019-04-18. HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The firm is focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. The Company’s replicating and non-replicating technologies are engineered to induce durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. Its oncology programs include HB-200 and HB-700, all of which use its replicating technology. HB-200 is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) cancers in a Phase I/II clinical trial. HB-700 is in preclinical development for the treatment of KRAS mutated cancers, including lung, colorectal and pancreatic cancers. Its Hepatitis B (HBV) program, HB-400, and its Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in a partnership with Gilead Sciences, Inc.
Company Info
HOOKIPA PHARMA INC
350 Fifth Avenue, 72Nd Floor, Suite 7240
New York City NEW YORK 10118 US
CEO: Joern Aldag
Employees: 165
Company Website: https://www.hookipapharma.com/
Investor Relations: https://ir.hookipapharma.com/
Phone: 114318906360
HOOK FAQ
What is the stock price of HOOK?
The current stock price of HOOK is 1.94 USD.
What is the symbol for HOOKIPA PHARMA INC stock?
The exchange symbol of HOOKIPA PHARMA INC is HOOK and it is listed on the Nasdaq exchange.
On which exchange is HOOK stock listed?
HOOK stock is listed on the Nasdaq exchange.
Is HOOK a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for HOOK, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of HOOK.
Does HOOK stock pay dividends?
HOOK does not pay a dividend.
What is the Price/Earnings (PE) ratio of HOOK?
HOOK does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.72).
What is the Short Interest ratio of HOOK stock?
The outstanding short interest for HOOK is 1.92% of its float.
HOOK Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to HOOK. When comparing the yearly performance of all stocks, HOOK is a bad performer in the overall market: 97.64% of all stocks are doing better.
HOOK Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to HOOK. While HOOK has a great health rating, there are worries on its profitability.
HOOK Financial Highlights
Over the last trailing twelve months HOOK reported a non-GAAP Earnings per Share(EPS) of -3.72. The EPS increased by 55.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -39.53% | ||
| ROE | -60.4% | ||
| Debt/Equity | 0 |
HOOK Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to HOOK. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 81.65% and a revenue growth 160.99% for HOOK